DocuSign
Digital Transaction Management platform that helps companies keep processes 100% digital from start to finish, accelerating transactions and reducing costs. Listed on Nasdaq in 2018.
Digital Transaction Management platform that helps companies keep processes 100% digital from start to finish, accelerating transactions and reducing costs. Listed on Nasdaq in 2018.
Now known as Standard BioTools Inc, Fluidigm’s technologies and products based on microfluidics and mass cytometry enable the exploration and analysis of individual cells, as well as the industrial application of genomics. Listed on NASDAQ in 2011.
A large-scale cell culture manufacturing site for the production of monoclonal antibodies and recombinant proteins. Acquired by Lonza Group in 2008.
Pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. Listed on NASDAQ in 2018.
Hazel Technologies is a company that develops and markets postharvest biotechnology solutions to reduce food waste and improve the quality of fruits and vegetables.
Hazel Technologies Read More »
Ember is a global temperature control brand and technology platform whose mission is to revolutionize the way people eat, drink and live. Founded by inventor and serial entrepreneur Clay Alexander, Ember creates, designs, and develops temperature control products that offer people complete customization. The award-winning Ember Travel Mug and Ember Mug are the most advanced
Ember Technologies (Ember Lifesciences) Read More »
GoSecure provides highly scalable big data endpoint threat detection and response solutions with behavioural analytics that helps organizations gain real-time visibility and context of their endpoints for threat detection and remediation.
GoSecure (fka CounterTack) Read More »
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates to improve the quality of life and survival for people with cancer.
Aetion is a health care technology company that delivers real-world evidence for biopharma companies, payers, regulators, and HTA agencies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value across the product life cycle.